Abstract
Complications of cirrhosis are the main cause of hospital admissions in liver units. In areas where HCV is prevalent, most of these admissions are attributable to HCV-related cirrhosis (HCV-cirrhosis). This study assessed the impact of direct-acting antivirals (DAA) in the profile of patients with liver disease admitted to a referral liver unit from a university hospital. We registered hospital admissions resulting from cirrhosis to the Liver Unit of the Hospital Clinic of Barcelona, from 2011 to 2014 (pre-DAA period) and from 2015 to 2019 (post-DAA period). From a total of 14,865 hospital admissions, 10,053 resulted from cirrhosis (corresponding to 6,272 patients). The number and proportion of hospital admissions because of HCV-cirrhosis remained stable during the period 2011-2014 (525 per year, 48.8% of the total), but decreased progressively after 2015 (p <0.001), reaching <300 (27.1%) admissions in 2019. Similarly, HCV-cirrhosis accounted for 3,885 inpatient days per year (44.9%) during the pre-DAA period and decreased steadily after 2015 (p >0.001), reaching only 1,909 inpatient days (22%) in 2019. The figures for intensive care unit admissions followed a similar pattern. By means of a slope analysis (binomial regression m...Continue Reading
References
May 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Angelo SangiovanniMassimo Colombo
May 26, 2010·Alimentary Pharmacology & Therapeutics·W AlazawiG R Foster
Apr 24, 2013·The New England Journal of Medicine·Eric LawitzEdward J Gane
May 15, 2013·Journal of Hepatology·Christophe HézodeUNKNOWN CUPIC Study Group
Jan 17, 2014·The New England Journal of Medicine·Mark S SulkowskiUNKNOWN AI444040 Study Group
Jan 28, 2014·Alimentary Pharmacology & Therapeutics·Z M YounossiS C Gordon
Aug 1, 2014·Lancet·Eric LawitzIra M Jacobson
Jan 6, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xavier FornsFrançois Habersetzer
Jul 17, 2015·Alimentary Pharmacology & Therapeutics·M MandorferP Ferenci
Apr 17, 2016·Journal of Hepatology·María ReigJordi Bruix
Jun 29, 2016·Journal of Hepatology·Fabio ContiStefano Brillanti
Dec 25, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jennifer A FlemmingNorah A Terrault
Jun 7, 2017·The American Journal of Gastroenterology·Sabela LensUNKNOWN Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collaborating Group
Jul 25, 2017·Gastroenterology·Sabela LensJuan Carlos García-Pagán
Jan 9, 2018·Lancet·Alejandro FornerJordi Bruix
Feb 27, 2018·Journal of Hepatology·Gonzalo CrespoMiquel Navasa
Mar 15, 2018·Gastroenterology·Omar El-SherifMichael P Curry
May 1, 2018·Gastroenterology·Martín BonacciXavier Forns
May 8, 2018·Annals of Hepatology·Suyan G R Dos SantosGabriela P Coral
Mar 12, 2019·Expert Review of Anti-infective Therapy·Lai Wei, Yi-Hsiang Huang
Apr 2, 2019·Alimentary Pharmacology & Therapeutics·Hashem B El-SeragJennifer R Kramer
Apr 24, 2019·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·D SchanzerJ Feld
Jan 20, 2020·Journal of Hepatology·Sandrine FaivreRichard S Finn
Feb 7, 2020·Journal of Clinical and Experimental Hepatology·Deepa ShresthaRadha K Dhiman
Mar 29, 2020·Gut·Sharon J HutchinsonDavid Goldberg
Citations
Oct 12, 2020·Journal of Hepatology·Javier CrespoJoaquín Cabezas
Jan 13, 2021·Journal of Endocrinological Investigation·M L MorieriUNKNOWN DARWIN-T2D Network of the Italian Diabetes Society
Aug 10, 2021·World Journal of Gastroenterology : WJG·Pietro TorreMarcello Persico